1. Introduction
Aging corresponds to the breakdown of cellular and tissue function over time, which is associated with increased prevalence of chronic diseases (e.g., neurodegenerative and metabolic disorders, cancer), ultimately leading to death. Evidence in invertebrate model organisms and human studies support the idea that aging is regulated at the genetic level but also by nongenetic factors [1,2]. Interestingly, even the lifespan of isogenic individuals reveals large differences between the first and last death in controlled environments [3], suggesting that even small environment variations may dramatically impact aging and lifespan. A number of environmental modulators of the aging process include dietary interventions [4], upregulated stress response [5], physical exercise [6], and circadian rhythms [7].
The strictest definition of āepigeneticsā only covers phenotypic changes that are heritable through generations without underlying changes to the genetic material [8]. However, in the broader definition, which will be used hereafter, āepigeneticsā encompasses alterations at the level of chromatin that may play a significant role in regulating gene expression. In eukaryotic cells, chromatin corresponds to a nucleoproteic structural polymer, whose basic units are nucleosomes. Nucleosomes are composed of ā¼150 bp DNA fragments wrapped around octamers of histone proteins, each unit containing two H2A, H2B, H3, and H4 histone proteins, which can be replaced by functional histone variants at specific loci (e.g., H2A.Z, H3.3, CENP-A) [9]. Chromatin can be found in two main states: euchromatin, a loose compartment permissive to transcription, and heterochromatin, a compact compartment that contains repressed regions of the genome. According to the āhistone codeā hypothesis, combinations of histone posttranslational modifications are thought to modulate the accessibility and expression of underlying genes [10]. DNA methylation constitutes another layer of epigenetic regulation, the most well-studied type of which occurs in āCpGā dinucleotides [11]. A final key layer of epigenetic regulation is attained through modulation of nucleosome positioning by ATP-dependent chromatin remodelers (e.g., SWI/SNF), which impacts regulatory sequence accessibility and higher-order chromatin compaction [12]. Several classes of noncoding RNAs (i.e., miRNAs, circRNAs, and lncRNAs) have been found to be able to modify transcriptional regulation and sometimes impact the chromatin landscape [13ā15].
Epigenetic alterations are considered one of the hallmarks (pillars) of the aging process [16,17], a role supported by many changes to chromatin marks throughout life and by the impact of interference with chromatin regulatory complexes on the lifespan of model organisms [18ā20,209]. Interestingly, accumulating evidence suggests that age-related epigenomic changes may interact with other hallmarks of aging, such as genome instability or loss of protein homeostasis [19]. Emerging evidence suggests that specific species of these ncRNA may become misregulated with aging [22ā25] and may even partially drive aging or age-related diseases phenotypes [22,25,26]. In this review, we will focus on the potential impact and changes in DNA and histone modifications throughout aging.
To this date, most of the knowledge of chromatin regulation remodeling with age has relied on global assessment of changes. Only a few studies have attempted to interrogate genome-wide locus-specific epigenomic changes with aging, with the exception of DNA methylation studies. Understanding the global and locus-specific epigenomic changes that accumulate during aging, identifying corresponding molecular regulators of health and lifespan, will be crucial to eventually increase healthy youthful years of life, and potentially reverse some aspects of aging.